DSM Biomedical
DSM Biomedical breakthroughs enable healthcare providers to address key problems associated with one of the greatest challenges facing the world today: our ageing population. Average life expectancy is increasing across the globe driven by better healthcare and higher standards of living. More age-related diseases are straining our healthcare systems.
DSM is helping to relieve that strain by applying radical developments in implants, medical device coatings and drug delivery systems. These breakthroughs improve the effectiveness of joint replacements, facilitating safer, cost-effective and less painful surgery, and provide more effective, targeted treatment of diseases.
Since 2004 when we launched our first biomedical product: a suture made with Dyneema Purity®, we’ve gone on to rapidly establish a leadership position in this market.
DSM is the only company with a broad portfolio covering all major uses of biomedical materials:
- Cardiovascular and vascular, orthopaedic, ophthalmic, urinary and neurological applications – DSM delivers standard and customized biomedical materials and coatings for the production of medical devices, as well as customized drug delivery systems.
